Skip Navigation

Global Malaria Action Plan 2016-2030 open for public review

A public review of the penultimate version of the GMAP2 - "Towards a Malaria Free-World: A Global Case for Investment and Action 2016-2030" - is open until 18 March.

ACT Now For a Malaria Free World: video for your use

Visit our multimedia section to watch videos and animations, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

News from our Partners

An independent review examined the impact of Roll Back Malaria control campaigns on primary school education in 14 sub-Saharan African countries. The campaign reveals itself as a cost-effective strategy to improve children's educational attainment.

Malaria research publications

Browse through more than 70 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.